Vasoview Hemopro 2 Endoscopic Vessel Harvesting System Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Maquet Cardiovascular, LLC is recalling 205 units of the Vasoview Hemopro 2 device due to exposure to an out-of-specification sterilization dose.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 10, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Maquet Cardiovascular, LLC initiated a recall after Getinge identified that Vasoview Hemopro 2 devices from Lot 3000547797 were exposed to an out-of-specification sterilization dose during a gamma sterilization run (Run ID 1183-28782A) performed by STERIS at its Whippany, NJ facility between March 31 and April 1 of 2026.
Which Products Are Affected
The Vasoview Hemopro 2 Endoscopic Vessel Harvesting System (Model VH-4000; UDI 00607567700406) from Serial/Lot Number 3000547797. A total of 205 units are affected. Distribution was limited to US Nationwide in the states of NY, CA, SC, FL, TX, GA, OR. The recall number is Z-2741-2026 and it is classified as Class II.
What You Should Do
Consumers with questions should contact the recalling firm Maquet Cardiovascular, LLC.
Why This Matters
The affected devices are a sterile, single-use Class II device cleared under 510(k) number K101274, and the sterilization issue impacts product safety for users.
Source
FDA recall number Z-2741-2026, event ID 99259.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,041 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 10, 2026.
Frequently Asked Questions
Common questions about this FDA recall.